Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems

TH Baryakova, BH Pogostin, R Langer… - Nature Reviews Drug …, 2023 - nature.com
Poor medication adherence is a pervasive issue with considerable health and
socioeconomic consequences. Although the underlying reasons are generally understood …

The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling

RMGJ Houben, PJ Dodd - PLoS medicine, 2016 - journals.plos.org
Background The existing estimate of the global burden of latent TB infection (LTBI) as “one-
third” of the world population is nearly 20 y old. Given the importance of controlling LTBI as …

[HTML][HTML] Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020

TR Sterling - MMWR. Recommendations and Reports, 2020 - cdc.gov
Comprehensive guidelines for treatment of latent tuberculosis infection (LTBI) among
persons living in the United States were last published in 2000 (American Thoracic Society …

Four-month rifapentine regimens with or without moxifloxacin for tuberculosis

SE Dorman, P Nahid, EV Kurbatova… - … England Journal of …, 2021 - Mass Medical Soc
Background Rifapentine-based regimens have potent antimycobacterial activity that may
allow for a shorter course in patients with drug-susceptible pulmonary tuberculosis. Methods …

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of …

DM Lewinsohn, MK Leonard, PA LoBue… - Clinical Infectious …, 2017 - academic.oup.com
Abstract Background. Individuals infected with Mycobacterium tuberculosis (Mtb) may
develop symptoms and signs of disease (tuberculosis disease) or may have no clinical …

What we know about tuberculosis transmission: an overview

G Churchyard, P Kim, NS Shah… - The Journal of …, 2017 - academic.oup.com
Tuberculosis remains a global health problem with an enormous burden of disease,
estimated at 10.4 million new cases in 2015. To stop the tuberculosis epidemic, it is critical …

Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis

A Roy, M Eisenhut, RJ Harris, LC Rodrigues, S Sridhar… - Bmj, 2014 - bmj.com
Objectives To determine whether BCG vaccination protects against Mycobacterium
tuberculosis infection as assessed by interferon γ release assays (IGRA) in children. Design …

Four-gene pan-African blood signature predicts progression to tuberculosis

S Suliman, EG Thompson, J Sutherland… - American journal of …, 2018 - atsjournals.org
Rationale: Contacts of patients with tuberculosis (TB) constitute an important target
population for preventive measures because they are at high risk of infection with …

After 2015: infectious diseases in a new era of health and development

C Dye - Philosophical Transactions of the Royal Society …, 2014 - royalsocietypublishing.org
Running over timescales that span decades or centuries, the epidemiological transition
provides the central narrative of global health. In this transition, a reduction in mortality is …

Tuberculosis control and elimination 2010–50: cure, care, and social development

K Lönnroth, KG Castro, JM Chakaya, LS Chauhan… - The lancet, 2010 - thelancet.com
Rapid expansion of the standardised approach to tuberculosis diagnosis and treatment that
is recommended by WHO allowed more than 36 million people to be cured between 1995 …